Analysis of Prognosis and Immune Microenvironment of Protein Kinase C Substrate 80K-H in Diabetic Lung Cancer Patients
This extensive investigation positioned PRKCSH as a critical prognostic biomarker and a promising therapeutic target for personalized immunotherapeutic strategies in the management of LUAD.
Authors
- Xiang Ying Li
- Cun Feng Li
- Yue Feng
- Hong Qiao
Institutions
- Harbin Medical University (CN)
- Liaoning University of Traditional Chinese Medicine (CN)
- Shaoxing Second Hospital (CN)
- Shenyang Fifth People Hospital (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2026-03-05
- DOI
- https://doi.org/10.14740/wjon2663
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00